Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Asia-Pacific biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2011 annual average exchange rates.
The Asia-Pacific biotechnology market had total revenue of $63,107.2 million in 2010, representing a compound annual growth rate (CAGR) of 11.6% between 2006 and 2010.
Medical/Healthcare sales proved the most lucrative for the Asia-Pacific biotechnology market in 2010, with total revenues of $34,864.8 million, equivalent to 55.2% of the market's overall value.
The performance of the market is forecast to decelerate marginally, with an anticipated CAGR of 11.5% for the five-year period 2010 - 2015, which is expected to drive the market to a value of $108,536.6 million by the end of 2015.

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Asia-Pacific

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Asia-Pacific

Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific biotechnology market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Asia-Pacific economy

Key Questions Answered

What was the size of the Asia-Pacific biotechnology market by value in 2010?

What will be the size of the Asia-Pacific biotechnology market in 2015?

What factors are affecting the strength of competition in the Asia-Pacific biotechnology market?

How has the market performed over the last five years?

What are the main segments that make up Asia-Pacific's biotechnology market?

EXECUTIVE SUMMARY
MARKET OVERVIEW
- Market definition
- Research highlights
- Market analysis
MARKET VALUE
MARKET SEGMENTATION I
MARKET SEGMENTATION II
FIVE FORCES ANALYSIS
- Summary
- Buyer power
- Supplier power
- New entrants
- Substitutes
- Rivalry
LEADING COMPANIES
- Astellas Pharma
- Kyowa Hakko Kirin Co., Ltd.
- Mitsubishi Tanabe Pharma Corporation
MARKET FORECASTS
- Market value forecast
APPENDIX
- Methodology
- Industry associations
- Related Datamonitor research
- Disclaimer
ABOUT DATAMONITOR
- Premium Reports
- Summary Reports
- Datamonitor consulting
LIST OF TABLES
- Table 1: Asia-Pacific biotechnology market value: $ million, 2006-10
- Table 2: Asia-Pacific biotechnology market segmentation I:% share, by value, 2010
- Table 3: Asia-Pacific biotechnology market segmentation II: % share, by value, 2010
- Table 4: Astellas Pharma: key facts
- Table 5: Astellas Pharma: key financials ($)
- Table 6: Astellas Pharma: key financials (¥)
- Table 7: Astellas Pharma: key financial ratios
- Table 8: Kyowa Hakko Kirin Co., Ltd.: key facts
- Table 9: Kyowa Hakko Kirin Co., Ltd.: key financials ($)
- Table 10: Kyowa Hakko Kirin Co., Ltd.: key financials (¥)
- Table 11: Kyowa Hakko Kirin Co., Ltd.: key financial ratios
- Table 12: Mitsubishi Tanabe Pharma Corporation: key facts
- Table 13: Mitsubishi Tanabe Pharma Corporation: key financials ($)
- Table 14: Mitsubishi Tanabe Pharma Corporation: key financials (¥)
- Table 15: Mitsubishi Tanabe Pharma Corporation: key financial ratios
- Table 16: Asia-Pacific biotechnology market value forecast: $ million, 2010-15
LIST OF FIGURES
- Figure 1: Asia-Pacific biotechnology market value: $ million, 2006-10
- Figure 2: Asia-Pacific biotechnology market segmentation I:% share, by value, 2010
- Figure 3: Asia-Pacific biotechnology market segmentation II: % share, by value, 2010
- Figure 4: Forces driving competition in the biotechnology market in Asia-Pacific, 2010
- Figure 5: Drivers of buyer power in the biotechnology market in Asia-Pacific, 2010
- Figure 6: Drivers of supplier power in the biotechnology market in Asia-Pacific, 2010
- Figure 7: Factors influencing the likelihood of new entrants in the biotechnology market in Asia-Pacific, 2010
- Figure 8: Factors influencing the threat of substitutes in the biotechnology market in Asia-Pacific, 2010
- Figure 9: Drivers of degree of rivalry in the biotechnology market in Asia-Pacific, 2010
- Figure 10: Astellas Pharma: revenues & profitability
- Figure 11: Astellas Pharma: assets & liabilities
- Figure 12: Kyowa Hakko Kirin Co., Ltd.: revenues & profitability
- Figure 13: Kyowa Hakko Kirin Co., Ltd.: assets & liabilities
- Figure 14: Mitsubishi Tanabe Pharma Corporation: revenues & profitability
- Figure 15: Mitsubishi Tanabe Pharma Corporation: assets & liabilities
- Figure 16: Asia-Pacific biotechnology market value forecast: $ million, 2010-15

Pharmaceutical Market Research

Biotechnology in Asia-Pacific